UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Vaccine, 2020-07, Vol.38 (33), p.5119-5122

2020

Volltextzugriff (PDF)

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

Journal of adolescent health, 2009, Vol.44 (1), p.33-40

2009

Volltextzugriff (PDF)

Patterns and Disparities in Human Papillomavirus (HPV) Vaccine Uptake for Young Female Adolescents among U.S. States: NIS-Teen (2008-2016)

Cancer epidemiology, biomarkers & prevention, 2020-07, Vol.29 (7), p.1458-1467

2020

Volltextzugriff (PDF)

The origin of Human Papillomavirus (HPV) — induced cervical squamous cancer

Current opinion in virology, 2021-12, Vol.51, p.111-118

2021

Volltextzugriff (PDF)

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Vaccine, 2013-11, Vol.31 (47), p.5500-5505

Osazuwa-Peters, N

2013

Volltextzugriff (PDF)

Towards elimination of cervical cancer – human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries

The Lancet regional health. Western Pacific, 2023-10, Vol.39, p.100860-100860, Article 100860

2023

Volltextzugriff (PDF)

Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule

Canada communicable disease report, 2016-07, Vol.42 (7), p.149-151

2016

Volltextzugriff (PDF)

Will humor increase the effectiveness of human papillomavirus (HPV) advertising? exploring the role of humor, STD information, and knowledge

Journal of marketing communications, 2023-07, Vol.29 (5), p.491-509

2023

Volltextzugriff (PDF)

Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma

Biochemical journal, 2012-04, Vol.443 (2), p.339-353

2012

Volltextzugriff (PDF)

'en_US': 'Papillomavirus phylogeny and its correlation with human papillomavirus (HPV) and animal - literature review', 'es_ES': 'Filogenia del virus del papiloma y su correlación con el virus del papiloma humano y animal (Human papillomavirus\xa0- VPH) - revisión de la literatura', 'pt_BR': 'Filogenia do papilomavírus e sua correlação com papilomavírus humano (Human papillomavirus – HPV) e animal - revisão de literatura'

PUBVET, 2022-02, Vol.1 (6-07)

Rachel Siqueira de Queiroz Simões Marins

2022

Volltextzugriff (PDF)

Kosovo women's knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer

BMC women's health, 2021-10, Vol.21 (1), p.354-6, Article 354

2021

Volltextzugriff (PDF)

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males

Cochrane database of systematic reviews, 2019-11, Vol.2019 (11)

2019

Volltextzugriff (PDF)

(−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α

Cancer chemotherapy and pharmacology, 2013-03, Vol.71 (3), p.713-725

2013

Volltextzugriff (PDF)

Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma

Oral oncology, 2014-12, Vol.50 (12), p.1149-1156

2014

Volltextzugriff (PDF)

Abandoning Medical Authority: When Medical Professionals Confront Stigmatized Adolescent Sex and the Human Papillomavirus (HPV) Vaccine

Journal of health and social behavior, 2019-06, Vol.60 (2), p.240-256

Fenton, Anny T.

2019

Volltextzugriff (PDF)

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Infectious agents and cancer, 2023-05, Vol.18 (1), p.29-29, Article 29

2023

Volltextzugriff (PDF)

Model of Human Tongue Squamous Cell Lines Stably Transfected with Human Papillomavirus (HPV)16 E6 and E7 Genes and Biological Characteristic Analysis

BioMed research international, 2021, Vol.2021, p.9968691-12

2021

Volltextzugriff (PDF)

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries

PloS one, 2017-06, Vol.12 (6), p.e0177773-e0177773

2017

Volltextzugriff (PDF)

Human papillomavirus (HPV) in pregnancy – An update

European journal of obstetrics & gynecology and reproductive biology, 2021-09, Vol.264, p.340-348

2021

Volltextzugriff (PDF)

Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006-2015): a need for evidence-based policy

Risk management and healthcare policy, 2017-01, Vol.10, p.29-32

2017

Volltextzugriff (PDF)

Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019

Vaccine, 2022-03, Vol.40 (Suppl 1), p.A38-A48

2022

Volltextzugriff (PDF)

“Saving lives”: Adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria

Social science & medicine (1982), 2016-03, Vol.153, p.193-200

Paul, Katharina T.

2016

Volltextzugriff (PDF)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study

Journal of clinical virology, 2022-09, Vol.154, p.105237-105237, Article 105237

2022

Volltextzugriff (PDF)

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

BMC public health, 2012-10, Vol.12 (1), p.872-872, Article 872

2012

Volltextzugriff (PDF)

Healthcare professional’s promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review

Vaccine, 2022-04, Vol.40 (19), p.2656-2666

2022

Volltextzugriff (PDF)

1 – 25 von 56.194

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

SprachePortugiesisch

ThemaMiddle Aged

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(49.731)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(39.687)
Life Sciences & Biomedicine
(36.129)
Humans
(24.514)
Human Papillomavirus
(20.029)
Female
(13.622)
Cervical Cancer
(11.807)
Oncology
(9.599)
Cancer
(8.950)
Vaccines
(6.879)
Tumors
(6.636)
Infections
(5.242)
Immunization
(4.805)
Proteins
(4.672)
Immunology
(4.643)
Animals
(4.566)
Health Aspects
(4.540)
Risk Factors
(4.486)
Review
(4.308)
Hpv
(4.201)
Virology
(4.200)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(35.132)
Ingenta
(31.505)
MEDLINE
(26.121)
IngentaConnect Journals
(20.853)
Elsevier ScienceDirect Journals Complete
(11.050)
SpringerLink
(8.049)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(7.931)
Publisher website
(5.050)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(2.801)
Taylor & Francis Journals Auto-Holdings Collection
(2.675)
Nature
(2.485)
Taylor & Francis
(1.799)
Taylor & Francis Online
(1.747)
Wiley-Blackwell Journals
(1.726)
Nexis Uni
(1.422)
SAGE Publications
(1.296)
Applied Social Sciences Index & Abstracts (ASSIA)
(1.071)
Wiley Online Library Full Collection 2018
(977)
JSTOR
(819)
BMJ
(613)
Journals@Ovid Full Text
(0)

16 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(1.892)
Vaccine
(1.670)
Cancers
(1.219)
International Journal Of Molecular Sciences
(780)
Cancer Research
(751)
Vaccines
(738)
Journal Of Virology
(668)
Scientific Reports
(652)
Gynecologic Oncology
(646)
Virology
(637)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

Patterns and Disparities in Human Papillomavirus (HPV) Vaccine Uptake for Young Female Adolescents among U.S. States: NIS-Teen (2008-2016)

The origin of Human Papillomavirus (HPV) — induced cervical squamous cancer

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Towards elimination of cervical cancer – human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries

Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule

Will humor increase the effectiveness of human papillomavirus (HPV) advertising? exploring the role of humor, STD information, and knowledge

Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma

Kosovo women's knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males

(−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α

Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma

Abandoning Medical Authority: When Medical Professionals Confront Stigmatized Adolescent Sex and the Human Papillomavirus (HPV) Vaccine

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Model of Human Tongue Squamous Cell Lines Stably Transfected with Human Papillomavirus (HPV)16 E6 and E7 Genes and Biological Characteristic Analysis

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries

Human papillomavirus (HPV) in pregnancy – An update

Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006-2015): a need for evidence-based policy

Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019

“Saving lives”: Adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

Healthcare professional’s promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review

Aktive Filter

Suchergebnisse filtern